UE LifeSciences makes non-invasive medical devices for early cancer detection, designed for community health workers.
Founded in 2009 and headquartered in Philadelphia, US, UE LifeSciences develops non-invasive medical devices for early cancer detection, including the iBreastExam breast screening tool and the CervAIcal mobile colposcope. Its devices are sold to governments, healthcare providers and NGOs in markets such as India, Malaysia, Colombia and South Africa. The company raised USD 1.2 million in October 2016, with Capria Ventures among its investors, and is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in